Science

Can lowering high blood pressure be as easy as moving your ear?

A tiny device that delivers electrical pulses to the ear may offer a new way to treat stubborn high blood pressure. In a clinical trial led by researchers at Queen Mary University of London, the technology proved to be safe, well tolerated, and useful for patients to use at home.

Although the treatment did not significantly reduce blood pressure compared to the placebo device in all participants, the researchers saw encouraging results in patients with high blood pressure. The findings suggest that stimulating the nerves in the ear may eventually help some people whose blood pressure remains high despite taking medication.

The results appear in the SCRATCH-HTN study, published in High blood pressurejournal of the American Heart Association. The researchers stress that larger studies are needed to determine whether this approach can provide meaningful benefits and which patients may respond best.

How Cochlear Nerve Stimulation Can Lower Blood Pressure

The experimental treatment uses a technique called transcutaneous autonomic neuromodulation (tAN), which aims to influence the autonomic nervous system. This network of nerves automatically controls vital body functions, including heart rate, digestion, and blood pressure.

By delivering mild electrical signals to the nerves in the ear, researchers hope to influence the body’s natural processes for controlling blood pressure without requiring an invasive procedure.

The handheld device, developed by Afferent Medical Solutions, uses two small clips placed on the tragus, a small flap of cartilage located just before the ear canal. These clips deliver mild electrical stimulation, allowing patients to self-treat without visiting a clinic.

A Clinical Trial Evaluates the Device in 63 Patients

The clinical trial, funded by the National Institute for Health and Care Research (NIHR), enrolled 63 people with uncontrolled high blood pressure. All participants were already taking at least one medication to lower blood pressure, but their readings remained above recommended levels.

The researchers divided the participants into two groups randomly. One received active sensory stimulation, while the other used a sham designed to act as a comparison. This approach helped the researchers to test whether the electrical stimulation produced benefits beyond those associated with using the device itself.

Participants used their assigned devices for 30 minutes every day during the first two weeks. For the next 10 weeks, they reduced their sessions to once a week.

The results showed that the treatment was safe and generally comfortable for the participants. Many also followed the prescribed routine, suggesting that the technology could be used regularly at home.

However, when the researchers compared blood pressure changes across studies, they found no statistically significant difference between patients receiving active stimulation and those using a sham device.

Promising Results in Hypertensive Patients

Despite the lack of a significant overall benefit, the researchers identified a potentially important finding among participants who entered the trial with severe hypertension.

A prespecified subgroup analysis, meaning the researchers planned this comparison before examining the results, revealed a greater reduction in blood pressure among these patients when they received active nerve stimulation than sham treatment.

This finding suggests that the method may work better in people whose blood pressure is more difficult to control. However, the trial was small, and the results of the small group need to be confirmed in larger studies before any conclusions about its effectiveness can be drawn.

Dr Ajay Gupta, Chief Investigator, Clinical Reader at Queen Mary University of London and Consultant Physician at Barts Health NHS Trust, said:

“This is an exciting technology, which is very well received by the patient that could eventually provide a cheap, refined solution for millions. Although the test did not achieve significance in the entire unselected group, those with high blood pressure showed a clear decrease in blood pressure in the active group compared to the sham.

“As the first and most comprehensive study of its kind, this points to important research directions that can help us understand how non-invasive neuromodulation can benefit certain groups of patients with uncontrolled hypertension.”

A Potential New Option to Control Hard-to-Control Blood Pressure

High blood pressure, also known as hypertension, is a major contributor to heart disease and increases the risk of heart attack and stroke. It puts more stress on the blood vessels and heart, which can cause more damage over time.

Although medication helps many patients to control their condition, a large number continue to have high blood pressure above recommended levels even when treated.

This ongoing challenge has encouraged scientists to explore additional approaches that can complement existing drugs.

Auditory stimulation is one such thing. Because the device is small, doesn’t require surgery, and can be used at home, it may provide an ideal option if future research finds it reliably lowers blood pressure in certain patients.

For now, the findings represent the first step in proving a new treatment works. The researchers say larger clinical trials will be necessary to confirm promising results in high blood pressure patients and identify which groups, if any, would benefit most from this approach.


Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button